"Klinische Studien Infektiologie"

During the past decade, Epimed GmbH conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 10 clinical trials were completed, i.e. on average, 200% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Epimed GmbH" #1 sponsor was "Gilead Sciences" with 8 trials, followed by "Boehringer Ingelheim" with 4 trials sponsored, "Bionor Immuno AS" with 3 trials sponsored, "Abbott" with 2 trials sponsored and "ViiV Healthcare" with 2 trials sponsored. Other sponsors include 1 different institutions and companies that sponsored additional 11 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Epimed GmbH" #1 collaborator was "Pfizer" with 2 trials as a collaborator and "Celgene Corporation" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Epimed GmbH" are "HIV Infections" (11 trials), "HIV-1 Infection" (6 trials), "Acquired Immunodeficiency Syndrome" (2 trials), "HIV" (2 trials) and "NASH - Nonalcoholic Steatohepatitis" (2 trials). Many other conditions were trialed in "Epimed GmbH" in a lesser frequency.

Most popular intervention types in "Epimed GmbH" are "Drug" (22 trials), "Biological" (1 trials) and "Diagnostic Test" (1 trials). Other intervention types were less common.

The name of intervention was led by "FTC/TDF" (4 trials), "RTV" (4 trials), "Placebo" (3 trials), "ATV" (2 trials) and "COBI" (2 trials). Other intervention names were less common.

The vast majority of trials in "Epimed GmbH" are 25 trials for "All" genders.

Currently, there are NaN active trials in "Epimed GmbH". undefined are not yet recruiting, 3 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 19 completed trials in Epimed GmbH, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Epimed GmbH, 1 "Phase 1" clinical trials were conducted, 9 "Phase 2" clinical trials and 14 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".